An Intelligent Data-Driven Approach for Electrical Energy Load Management Using Machine Learning Algorithms

Data-driven electrical energy efficiency management is the emerging trend in electrical energy forecasting and management. This fusion of data science, artificial intelligence, and electrical energy management has turned out to be the most precise and robust energy management solution. The Smart Energy Informatics Lab (SEIL) of the Indian Institute of Technology (IIT) conducted an experimental study in 2019 to collect massive data on university campus energy consumption. The comprehensive comparative study preparatory to the recommendation of the best candidate out of 24 machine learning algorithms on the SEIL dataset is presented in this work. In this research work, an exhaustive parametric and empirical comparative study is conducted on the SEIL dataset for the recommendation of the optimal machine learning algorithm. The simulation results established the findings that Bagged Trees, Fine Trees, and Medium Trees are, respectively, the best-, second-best-, and third-best-performing algorithms in terms of efficacy. On the contrary, a reverse ranking is observed in terms of efficiency. This is grounded in the fact that Bagged Trees is most effective algorithm for the said application and Medium Trees is the most efficient one. Likewise, Fine Trees has the optimum tradeoff between efficacy and efficiency

A Hybrid Soft Computing Framework for Electrical Energy Optimization

Electricity is a significant and essential player in the modern world economy. It translates into the social, economic, and sectorial growth of any region. The scarcity of these resources demands a highly efficient and robust energy management system (EMS). In the recent literature, many artificial intelligence algorithms have been proposed to cater to the need for efficient and real-time decision-making. Moreover, the hybridization of these algorithms has also been proposed for optimum decision-making. In this paper, a hybrid soft-computing-based framework has been proposed for intelligent energy management and optimization. The proposed model has based on the evolutionary neuro-fuzzy approach that can predict the energy demand as an objective function and optimize the energy within the given constraints. The future extension of this work will be the implementation and validation of the proposed framework on either a real application dataset or dataset opted from the benchmark repositor

A Novel Deep Learning Architecture for Data-Driven Energy Efficiency Management (D2EEM) - Systematic Survey

The Energy Management System (EMS) is the cost-effectiveness, robustness, and flexible approach for energy efficiency management (EEM). Data-Driven Energy Efficiency Management (D2EEM) is a recent advancement in EMS. The D2EEM is the blend of data science and artificial intelligence for EEM. Due to the highly tolerant to the performance plateau and unconstraint to the feature extraction, Deep Learning (DL) facilitates handling big data-driven problems of EEM. To the best of the knowledge, the accurate and robust D2EEM is the pressing need. Moreover, the accurate pre-trained DL network for EEM is not available in the recent literature. In this work, a comprehensive study is presented to devise a D2EEM. Moreover, the architecture is suggested in connection to the research gap

Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial

Background: Tranexamic acid reduces surgical bleeding and reduces death due to bleeding in patients with trauma. Meta-analyses of small trials show that tranexamic acid might decrease deaths from gastrointestinal bleeding. We aimed to assess the effects of tranexamic acid in patients with gastrointestinal bleeding. Methods: We did an international, multicentre, randomised, placebo-controlled trial in 164 hospitals in 15 countries. Patients were enrolled if the responsible clinician was uncertain whether to use tranexamic acid, were aged above the minimum age considered an adult in their country (either aged 16 years and older or aged 18 years and older), and had significant (defined as at risk of bleeding to death) upper or lower gastrointestinal bleeding. Patients were randomly assigned by selection of a numbered treatment pack from a box containing eight packs that were identical apart from the pack number. Patients received either a loading dose of 1 g tranexamic acid, which was added to 100 mL infusion bag of 0·9% sodium chloride and infused by slow intravenous injection over 10 min, followed by a maintenance dose of 3 g tranexamic acid added to 1 L of any isotonic intravenous solution and infused at 125 mg/h for 24 h, or placebo (sodium chloride 0·9%). Patients, caregivers, and those assessing outcomes were masked to allocation. The primary outcome was death due to bleeding within 5 days of randomisation; analysis excluded patients who received neither dose of the allocated treatment and those for whom outcome data on death were unavailable. This trial was registered with Current Controlled Trials, ISRCTN11225767, and ClinicalTrials.gov, NCT01658124. Findings: Between July 4, 2013, and June 21, 2019, we randomly allocated 12 009 patients to receive tranexamic acid (5994, 49·9%) or matching placebo (6015, 50·1%), of whom 11 952 (99·5%) received the first dose of the allocated treatment. Death due to bleeding within 5 days of randomisation occurred in 222 (4%) of 5956 patients in the tranexamic acid group and in 226 (4%) of 5981 patients in the placebo group (risk ratio [RR] 0·99, 95% CI 0·82–1·18). Arterial thromboembolic events (myocardial infarction or stroke) were similar in the tranexamic acid group and placebo group (42 [0·7%] of 5952 vs 46 [0·8%] of 5977; 0·92; 0·60 to 1·39). Venous thromboembolic events (deep vein thrombosis or pulmonary embolism) were higher in tranexamic acid group than in the placebo group (48 [0·8%] of 5952 vs 26 [0·4%] of 5977; RR 1·85; 95% CI 1·15 to 2·98). Interpretation: We found that tranexamic acid did not reduce death from gastrointestinal bleeding. On the basis of our results, tranexamic acid should not be used for the treatment of gastrointestinal bleeding outside the context of a randomised trial

An Adaptive Federated Machine Learning-Based Intelligent System for Skin Disease Detection: A Step toward an Intelligent Dermoscopy Device

The prevalence of skin diseases has increased dramatically in recent decades, and they are now considered major chronic diseases globally. People suffer from a broad spectrum of skin diseases, whereas skin tumors are potentially aggressive and life-threatening. However, the severity of skin tumors can be managed (by treatment) if diagnosed early. Health practitioners usually apply manual or computer vision-based tools for skin tumor diagnosis, which may cause misinterpretation of the disease and lead to a longer analysis time. However, cutting-edge technologies such as deep learning using the federated machine learning approach have enabled health practitioners (dermatologists) in diagnosing the type and severity level of skin diseases. Therefore, this study proposes an adaptive federated machine learning-based skin disease model (using an adaptive ensemble convolutional neural network as the core classifier) in a step toward an intelligent dermoscopy device for dermatologists. The proposed federated machine learning-based architecture consists of intelligent local edges (dermoscopy) and a global point (server). The proposed architecture can diagnose the type of disease and continuously improve its accuracy. Experiments were carried out in a simulated environment using the International Skin Imaging Collaboration (ISIC) 2019 dataset (dermoscopy images) to test and validate the model’s classification accuracy and adaptability. In the future, this study may lead to the development of a federated machine learning-based (hardware) dermoscopy device to assist dermatologists in skin tumor diagnosis

Automatic Image Annotation for Small and Ad hoc Intelligent Applications using Raspberry Pi

The cutting-edge technology Machine Learning (ML) is successfully applied for Business Intelligence. Among the various pre-processing steps of ML, Automatic Image Annotation (also known as automatic image tagging or linguistic indexing) is the process in which a computer system automatically assigns metadata in the form of captioning or keywords to a digital image. Automatic Image Annotation (AIA) methods (which have appeared during the last several years) make a large use of many ML approaches. Clustering and classification methods are most frequently applied to annotate images. In addition, these proposed solutions require a high computational infrastructure. However, certain real-time applications (small and ad-hoc intelligent applications) for example, autonomous small robots, gadgets, drone etc. have limited computational processing capacity. These small and ad-hoc applications demand a more dynamic and portable way to automatically annotate data and then perform ML tasks (Classification, clustering etc.) in real time using limited computational power and hardware resources. Through a comprehensive literature study we found that most image pre-processing algorithms and ML tasks are computationally intensive, and it can be challenging to run them on an embedded platform with acceptable frame rates. However, Raspberry Pi is sufficient for AIA and ML tasks that are relevant to small and ad-hoc intelligent applications. In addition, few critical intelligent applications (which require high computational resources, for example, Deep Learning using huge dataset) are only feasible to run on more powerful hardware resources. In this study, we present the framework of “Automatic Image Annotation for Small and Ad-hoc Intelligent Application using Raspberry Pi” and propose the low-cost infrastructures (single node and multi node using Raspberry Pi) and software module (for Raspberry Pi) to perform AIA and ML tasks in real time for small and ad-hoc intelligent applications. The integration of both AIA and ML tasks in a single software module (with in Raspberry Pi) is challenging. This study will helpful towards the improvement in various practical applications areas relevant to small intelligent autonomous systems

A Novel Deep Learning Model for Sea State Classification Using Visual-Range Sea Images

Wind-waves exhibit variations both in shape and steepness, and their asymmetrical nature is a well-known feature. One of the important characteristics of the sea surface is the front-back asymmetry of wind-wave crests. The wind-wave conditions on the surface of the sea constitute a sea state, which is listed as an essential climate variable by the Global Climate Observing System and is considered a critical factor for structural safety and optimal operations of offshore oil and gas platforms. Methods such as statistical representations of sensor-based wave parameters observations and numerical modeling are used to classify sea states. However, for offshore structures such as oil and gas platforms, these methods induce high capital expenditures (CAPEX) and operating expenses (OPEX), along with extensive computational power and time requirements. To address this issue, in this paper, we propose a novel, low-cost deep learning-based sea state classification model using visual-range sea images. Firstly, a novel visual-range sea state image dataset was designed and developed for this purpose. The dataset consists of 100,800 images covering four sea states. The dataset was then benchmarked on state-of-the-art deep learning image classification models. The highest classification accuracy of 81.8% was yielded by NASNet-Mobile. Secondly, a novel sea state classification model was proposed. The model took design inspiration from GoogLeNet, which was identified as the optimal reference model for sea state classification. Systematic changes in GoogLeNet’s inception block were proposed, which resulted in an 8.5% overall classification accuracy improvement in comparison with NASNet-Mobile and a 7% improvement from the reference model (i.e., GoogLeNet). Additionally, the proposed model took 26% less training time, and its per-image classification time remains competitive

A Novel Deep Learning Model for Sea State Classification Using Visual-Range Sea Images

Wind-waves exhibit variations both in shape and steepness, and their asymmetrical nature is a well-known feature. One of the important characteristics of the sea surface is the front-back asymmetry of wind-wave crests. The wind-wave conditions on the surface of the sea constitute a sea state, which is listed as an essential climate variable by the Global Climate Observing System and is considered a critical factor for structural safety and optimal operations of offshore oil and gas platforms. Methods such as statistical representations of sensor-based wave parameters observations and numerical modeling are used to classify sea states. However, for offshore structures such as oil and gas platforms, these methods induce high capital expenditures (CAPEX) and operating expenses (OPEX), along with extensive computational power and time requirements. To address this issue, in this paper, we propose a novel, low-cost deep learning-based sea state classification model using visual-range sea images. Firstly, a novel visual-range sea state image dataset was designed and developed for this purpose. The dataset consists of 100,800 images covering four sea states. The dataset was then benchmarked on state-of-the-art deep learning image classification models. The highest classification accuracy of 81.8% was yielded by NASNet-Mobile. Secondly, a novel sea state classification model was proposed. The model took design inspiration from GoogLeNet, which was identified as the optimal reference model for sea state classification. Systematic changes in GoogLeNet’s inception block were proposed, which resulted in an 8.5% overall classification accuracy improvement in comparison with NASNet-Mobile and a 7% improvement from the reference model (i.e., GoogLeNet). Additionally, the proposed model took 26% less training time, and its per-image classification time remains competitive

Recent Developments in Coatings for Orthopedic Metallic Implants

Titanium, stainless steel, and CoCrMo alloys are the most widely used biomaterials for orthopedic applications. The most common causes of orthopedic implant failure after implantation are infections, inflammatory response, least corrosion resistance, mismatch in elastic modulus, stress shielding, and excessive wear. To address the problems associated with implant materials, different modifications related to design, materials, and surface have been developed. Among the different methods, coating is an effective method to improve the performance of implant materials. In this article, a comprehensive review of recent studies has been carried out to summarize the impact of coating materials on metallic implants. The antibacterial characteristics, biodegradability, biocompatibility, corrosion behavior, and mechanical properties for performance evaluation are briefly summarized. Different effective coating techniques, coating materials, and additives have been summarized. The results are useful to produce the coating with optimized properties

Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial

BackgroundTranexamic acid reduces surgical bleeding and reduces death due to bleeding in patients with trauma. Meta-analyses of small trials show that tranexamic acid might decrease deaths from gastrointestinal bleeding. We aimed to assess the effects of tranexamic acid in patients with gastrointestinal bleeding.MethodsWe did an international, multicentre, randomised, placebo-controlled trial in 164 hospitals in 15 countries. Patients were enrolled if the responsible clinician was uncertain whether to use tranexamic acid, were aged above the minimum age considered an adult in their country (either aged 16 years and older or aged 18 years and older), and had significant (defined as at risk of bleeding to death) upper or lower gastrointestinal bleeding. Patients were randomly assigned by selection of a numbered treatment pack from a box containing eight packs that were identical apart from the pack number. Patients received either a loading dose of 1 g tranexamic acid, which was added to 100 mL infusion bag of 0·9% sodium chloride and infused by slow intravenous injection over 10 min, followed by a maintenance dose of 3 g tranexamic acid added to 1 L of any isotonic intravenous solution and infused at 125 mg/h for 24 h, or placebo (sodium chloride 0·9%). Patients, caregivers, and those assessing outcomes were masked to allocation. The primary outcome was death due to bleeding within 5 days of randomisation; analysis excluded patients who received neither dose of the allocated treatment and those for whom outcome data on death were unavailable. This trial was registered with Current Controlled Trials, ISRCTN11225767, and ClinicalTrials.gov, NCT01658124.FindingsBetween July 4, 2013, and June 21, 2019, we randomly allocated 12 009 patients to receive tranexamic acid (5994, 49·9%) or matching placebo (6015, 50·1%), of whom 11 952 (99·5%) received the first dose of the allocated treatment. Death due to bleeding within 5 days of randomisation occurred in 222 (4%) of 5956 patients in the tranexamic acid group and in 226 (4%) of 5981 patients in the placebo group (risk ratio [RR] 0·99, 95% CI 0·82–1·18). Arterial thromboembolic events (myocardial infarction or stroke) were similar in the tranexamic acid group and placebo group (42 [0·7%] of 5952 vs 46 [0·8%] of 5977; 0·92; 0·60 to 1·39). Venous thromboembolic events (deep vein thrombosis or pulmonary embolism) were higher in tranexamic acid group than in the placebo group (48 [0·8%] of 5952 vs 26 [0·4%] of 5977; RR 1·85; 95% CI 1·15 to 2·98).InterpretationWe found that tranexamic acid did not reduce death from gastrointestinal bleeding. On the basis of our results, tranexamic acid should not be used for the treatment of gastrointestinal bleeding outside the context of a randomised trial.</div